Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026)
Fortrea Holdings' (FTRE) quarterly Receivables - Net came in at $654.4 million in Q2 2026, down 11.47% on a YoY basis from $739.2 million in Q2 2025, and up 5.62% quarter-over-quarter from $619.6 million in Q1 2026.
Analysis
Fortrea Holdings (FTRE) Receivables - Net (2022 - 2026) Analysis & Trends
Fortrea Holdings (FTRE) has reported Receivables - Net for 5 consecutive years, with $654.4 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Receivables - Net fell 11.47% year-over-year to $654.4 million; the trailing twelve-month figure through Jun 2026 stood at $654.4 million (down 11.47% YoY), and the FY2025 full-year result was $589.7 million, down 10.58% from the prior year.
- Receivables - Net improved to $654.4 million in Q2 2026 per FTRE's latest filing, from $619.6 million in the prior quarter.
- Across five years, Receivables - Net topped out at $1.0 billion in Q3 2023 and bottomed at $589.7 million in Q4 2025.
- Historically, Receivables - Net has averaged $785.4 million across 5 years, with a median of $709.0 million in 2024.
- The sharpest annual moves came in 2024 and 2025: Receivables - Net plunged 37.13% in 2024, then advanced 15.88% in 2025.
- Over 5 years, Receivables - Net stood at $1.0 billion in 2022, then fell by 3.3% to $988.5 million in 2023, then plunged by 33.28% to $659.5 million in 2024, then slipped by 10.58% to $589.7 million in 2025, then climbed by 10.97% to $654.4 million in 2026.
- According to Business Quant data, Receivables - Net over the past three periods registered $654.4 million, $619.6 million, and $589.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.77 Bn | 40.69 Bn | 1.44 Bn |
| 2 | Medpace Holdings | 16.50 Bn | 16.00 Bn | 201.64 Mn |
| 3 | Charles River Laboratories International | 13.37 Bn | 13.18 Bn | 452.07 Mn |
| 4 | Icon | 12.49 Bn | 11.56 Bn | 479.29 Mn |
| 5 | Fortrea Holdings | 1.58 Bn | 1.42 Bn | 139.20 Mn |
| 6 | Evotec SE | 642.83 Mn | 216.96 Mn | - |
| 7 | Ginkgo Bioworks Holdings | 422.55 Mn | 338.02 Mn | 18.44 Mn |
| 8 | Champions Oncology | 69.16 Mn | 69.16 Mn | 7.03 Mn |
| 9 | MindWalk Holdings | 59.83 Mn | 51.55 Mn | 1.82 Mn |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 654.40 Mn |
| Mar 31, 2026 | 619.60 Mn |
| Dec 31, 2025 | 589.70 Mn |
| Sep 30, 2025 | 663.20 Mn |
| Jun 30, 2025 | 739.20 Mn |
| Mar 31, 2025 | 729.00 Mn |
| Dec 31, 2024 | 659.50 Mn |
| Sep 30, 2024 | 689.10 Mn |
| Jun 30, 2024 | 637.90 Mn |
| Mar 31, 2024 | 941.00 Mn |
| Dec 31, 2023 | 988.50 Mn |
| Sep 30, 2023 | 1.05 Bn |
| Jun 30, 2023 | 1.01 Bn |
| Dec 31, 2022 | 1.02 Bn |